Abstract:Protein aggregation is a widespread phenomenon implicated in debilitating diseases like Alzheimer's, Parkinson's, and cataracts, presenting complex hurdles for the field of molecular biology. In this review, we explore the evolving realm of computational methods and bioinformatics tools that have revolutionized our comprehension of protein aggregation. Beginning with a discussion of the multifaceted challenges associated with understanding this process and emphasizing the critical need for precise predictive tools, we highlight how computational techniques have become indispensable for understanding protein aggregation. We focus on molecular simulations, notably molecular dynamics (MD) simulations, spanning from atomistic to coarse-grained levels, which have emerged as pivotal tools in unraveling the complex dynamics governing protein aggregation in diseases such as cataracts, Alzheimer's, and Parkinson's. MD simulations provide microscopic insights into protein interactions and the subtleties of aggregation pathways, with advanced techniques like replica exchange molecular dynamics, Metadynamics (MetaD), and umbrella sampling enhancing our understanding by probing intricate energy landscapes and transition states. We delve into specific applications of MD simulations, elucidating the chaperone mechanism underlying cataract formation using Markov state modeling and the intricate pathways and interactions driving the toxic aggregate formation in Alzheimer's and Parkinson's disease. Transitioning we highlight how computational techniques, including bioinformatics, sequence analysis, structural data, machine learning algorithms, and artificial intelligence have become indispensable for predicting protein aggregation propensity and locating aggregation-prone regions within protein sequences. Throughout our exploration, we underscore the symbiotic relationship between computational approaches and empirical data, which has paved the way for potential therapeutic strategies against protein aggregation-related diseases. In conclusion, this review offers a comprehensive overview of advanced computational methodologies and bioinformatics tools that have catalyzed breakthroughs in unraveling the molecular basis of protein aggregation, with significant implications for clinical interventions, standing at the intersection of computational biology and experimental research.

Prevention of amyloid‐like aggregation as a driving force of protein evolution

Molecular Simulations of Amyloid Structures, Toxicity, and Inhibition

Mechanisms and pathology of protein misfolding and aggregation

Protein Aggregation: Opposing Effects of Chaperones and Crowding

Protein aggregation: An overview

Factors influencing amyloid fibril formation

Proteins in Aggregates Functionally Impact Multiple Neurodegenerative Disease Models by Forming Proteasome-Blocking Complexes

Physicochemical Strategies for Inhibition of Amyloid Fibril Formation: an Overview of Recent Advances

Engineering and Evolution of Molecular Chaperones and Protein Disaggregases with Enhanced Activity

Modulation of Amyloid States by Molecular Chaperones

What Does Evolution Tell Us About The Structure Of A Functional Amyloid Protein?

Mechanistic Insights into the Role of Molecular Chaperones in Protein Misfolding Diseases: From Molecular Recognition to Amyloid Disassembly

Resolving the paradox for protein aggregation diseases: NMR structure and dynamics of the membrane-embedded P56S-MSP causing ALS imply a common mechanism for aggregation-prone proteins to attack membranes

Advanced computational approaches to understand protein aggregation

Computational studies of protein aggregation mediated by amyloid: Fibril elongation and secondary nucleation

Molecular chaperones in protein folding and proteostasis

Quality control of protein folding in extracellular space

Realization of Amyloid-like Aggregation as a Common Cause for Pathogenesis in Diseases

The unhappy chaperone

Non-native beta-sheet formation: insights into protein amyloidosis